Ian R. Kleckner on Relieving CIPN With Exercise
Ian R. Kleckner, PhD, Research Assistant Professor at University of Rochester Medical Center, discusses the benefits of exercise for patients with chemotherapy-induced peripheral neuropathy (CIPN).
Ian R. Kleckner, PhD, Research Assistant Professor at University of Rochester Medical Center, discusses the benefits of exercise for patients with chemotherapy-induced peripheral neuropathy (CIPN).
In a study that compared patients on chemotherapy who were given an exercise regimen of walking and resistance training to a control group of patients who were on chemotherapy alone, patient-reported outcomes revealed that those who exercised had a significantly lower incidence of CIPN. Further, Klecker also found that exercise was particularly effective for older patients, in which the control group experienced a large increase of CIPN and the exercise arm had little, if any, increase.
Shared Model of Care Post-HCT Offers Safe Follow-Up, Reduces Patient Burden
Published: March 19th 2025 | Updated: March 19th 2025Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality and similar quality of life to usual care.
